Rhinosinusitis is associated with increased symptoms and more frequent exacerbations among patients with bronchiectasis- data from the EMBARC registry

M. Shteinberg (Haifa, Israel), P. Goeminne (Leuven, Belgium), M. Loebinger (London, United Kingdom), C. Haworth (Cambridge, United Kingdom), F. Ringshausen (Hannover, Germany), K. Dimakou (Athens, Greece), M. Murris (Toulouse, France), M. Vendrell (Girona, Spain), R. Menendez (Valencia, Spain), R. Wilson (London, United Kingdom), A. Hill (Edinburgh, United Kingdom), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), F. Blasi (Milan, Italy), A. De Soyza (Newcastle upon Tyne, United Kingdom), S. Elborn (Belfast, United Kingdom), E. Polverino (Barcelona, Spain), J. Chalmers (Dundee, United Kingdom), S. Aliberti (Milan, United Kingdom)

Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Session: The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Session type: Poster Discussion
Number: 350
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Shteinberg (Haifa, Israel), P. Goeminne (Leuven, Belgium), M. Loebinger (London, United Kingdom), C. Haworth (Cambridge, United Kingdom), F. Ringshausen (Hannover, Germany), K. Dimakou (Athens, Greece), M. Murris (Toulouse, France), M. Vendrell (Girona, Spain), R. Menendez (Valencia, Spain), R. Wilson (London, United Kingdom), A. Hill (Edinburgh, United Kingdom), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), F. Blasi (Milan, Italy), A. De Soyza (Newcastle upon Tyne, United Kingdom), S. Elborn (Belfast, United Kingdom), E. Polverino (Barcelona, Spain), J. Chalmers (Dundee, United Kingdom), S. Aliberti (Milan, United Kingdom). Rhinosinusitis is associated with increased symptoms and more frequent exacerbations among patients with bronchiectasis- data from the EMBARC registry. 350

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Factors associated with frequent exacerbations in patients with severe asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 369s
Year: 2001

Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


Analysis of the causes for the frequent exacerbations and hospitalisations in patients with COPD
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009


Exacerbation phenotypes of frequent versus non-frequent exacerbators among severe asthma patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019


Are comorbidities related to frequent severe exacerbations of COPD?
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019

Severe outcomes of COVID-19 among patients with COPD and asthma
Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020
Year: 2021



Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study
Source: Eur Respir J, 58 (6) 2004474; 10.1183/13993003.04474-2020
Year: 2021



Characteristics of patients with frequent EXACT-PRO defined exacerbations
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019

Time trends in clinical characteristics of patients with severe asthma: data from the Belgian Severe asthma register (BSAR)
Source: International Congress 2018 – Tests and trends in asthma
Year: 2018

Analysis of causes and quality of patients‘ treatment with often severe asthma exacerbations
Source: Eur Respir J 2007; 30: Suppl. 51, 72s
Year: 2007

Daily symptom burden in patients with severe COPD
Source: Annual Congress 2010 - Palliative care, oxygen and community care for chronic lung disease
Year: 2010

Poor quality of life is associated with frequent exacerbations in moderate-to-severe COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 190s
Year: 2001

Acute exacerbation of COPD- What symptoms bothers patients the most: A survey study
Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions
Year: 2021


Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016



Clinical characteristics and burden of illness in a cohort of severe asthma patients
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016


Comorbidities in COPD patients are not associated to higher disease severity
Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation
Year: 2011


Disease management program for COPD patients with frequent exacerbations
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012


Exacerbations and symptoms remain common in patients with asthma control: A survey of 8000 patients in Europe
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013


Depressive symptoms among COPD patients are associated with increased healthcare utilization
Source: Eur Respir J 2004; 24: Suppl. 48, 15s
Year: 2004

Factors associated with the length of hospital stay in patients with acute exacerbations of asthma and COPD overlap syndrome
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015